WASHINGTON, DC -- Just before leaving office, the Biden administration has announced costly GLP-1 drugs often used for weight loss are among the 15 medications listed in the next round of Medicare price negotiations.
Just how much consumers will ultimately save on drugs like Ozempic depends on many factors... Including the incoming trump administration's approach to the negotiation process.
Only people eligible for medicare will benefit directly.
The 15 drugs on the list were used by more than five-million medicare enrollees.
The drugs treat a variety of diseases -- including asthma, cancer, and diabetes.
The negotiated prices would take effect in 20-27.
FacebookTwitterPinterestLinkedin